Single-dose vaccine could be the fourth approved in EU
Until EMA reviews its safety and effectiveness
50 million doses available from June following approval
CureVac's vaccine
While it claims authorisation is in progress
Emergency approval shifts burden, EC president warns
Some key information reiterated for a slow learner
AstraZeneca files for conditional marketing authorisation
Moderna to start delivery between Q1 and Q3
First vaccine recommended for authorisation
300 million doses
This time from Novavax
Hungary's plans to import and possibly use Sputnik V raise concerns
Under an "optimistic" scenario
European Commission takes decision.
Recommendations for Esmya approved by CHMP.
Esmya may remain on markets but with restrictions.
Analysts are split over after-tax profit.
European Medicines Agency is not a bearer of bad news only.
Jefferies comment EMA probe, Q4 results.